The incidence of pediatric cardiomyopathy in two regions of the United States

New England Journal of Medicine

Volumn 348, Issue 17, 2003, Pages 1647-1655

  Lipshultz, Steven E ^a,b,c,i   Sleeper, Lynn A ^d   Towbin, Jeffrey A ^e   Lowe, April M ^d   Orav, E John ^f   Cox, Gerald F ^b,c,g   Lurie, Paul R ^h   McCoy, Kristina L ^a   McDonald, Melissa A ^a   Messere, Jane E ^b   Colan, Steven D ^b,c  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d NEW ENGLAND RESEARCH INSTITUTES   (United States)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

^g GENZYME CORPORATION   (United States)

^h ALBANY MEDICAL COLLEGE   (United States)

ⁱ UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CARDIOMYOPATHY; CHILD; CHILDHOOD DISEASE; ETHNOLOGY; FEMALE; HEART DILATATION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; INCIDENCE; INFANT; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RESTRICTIVE CARDIOMYOPATHY; SEX; UNITED STATES;

ADOLESCENT; AGE DISTRIBUTION; CARDIOMYOPATHIES; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INCIDENCE; INFANT; MALE; NEW ENGLAND; OKLAHOMA; PROSPECTIVE STUDIES; REGISTRIES; SEX DISTRIBUTION; SOUTHWESTERN UNITED STATES;

EID: 0345636017     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMoa021715     Document Type: Article

References (38)

1. Lipshultz SE. Ventricular dysfunction clinical research in infants, children and adolescents. Prog Pediatr Cardiol 2000;12:1-28.
2. Schwartz ML, Cox GF, Lin AE, et al. Clinical approach to genetic cardiomyopathy in children. Circulation 1996;94:2021-38.
3. Kumar K, Thatai D, Saxena A, et al. Pediatric dilated cardiomyopathy: prognosis in a developing nation is comparable to developed nations. Int J Cardiol (in press).
4. Bilgic A, Ozbalas N, Ozkudu S, Ozer S, Ozme S. Cardiomyopathies in children: clinical, epidemiological and prognostic evaluation. Jpn Heart J 1990;31:789-97.
5. Evans R.W. Economic and social costs of heart transplantation. Heart Transplant 1982;1:243-51.
6. Gillum R.F. Idiopathic cardiomyopathy in the United States, 1970-1982. Am Heart J 1986;111:752-5.
7. Boucek MM, Faro A, Novick RJ, Bennett LE, Keck BM, Hosenpud JD. The Registry of the International Society of Heart and Lung Transplantation: Fourth Official Pediatric Report - 2000. J Heart Lung Transplant 2001;20:39-52.
8. Arola A, Jokimen E, Ruuskanen O, et al. Epidemiology of idiopathic cardiomyopathies in children and adolescents: a nationwide study in Finland. Am J Epidemiol 1997; 146:385-93.
9. Arola A, Touminen J, Ruuskanen O, Jokinen E. Idiopathic dilated cardiomyopathy in children: prognostic indicators and outcome. Pediatrics 1998;101:369-76.
10. Nugent AW, Daubeney PEF, Chondros P, et al. The epidemiology of childhood cardiomyopathy in Australia. N Engl J Med 2003; 348:1639-46.
11. Grenier MA, Osganian SK, Cox GF, et al. Design and implementation of the North American Pediatric Cardiomyopathy Registry. Am Heart J 2000;139:S86-S95.
12. Colan SD, Parness LA, Spevak PJ, Sanders SP. Developmental modulation of myocardial mechanics: age- and growth-related alterations in afterload and contractility. J Am Coll Cardiol 1992;19:619-29.
13. Estimates of the population of states by age, sex, race and Hispanic origin: 1990 to 1999. Washington, D.C.: Census Bureau, 1999. (Accessed April 1, 2003, at http://eire.census.gov/popest/archivesstate/st_sasrh.php.)
14. Cox GF, Sleeper LA, Lowe AM, et al. Variables associated with a known etiology of cardiomyopathy in children: a retrospective analysis of the Pediatric Cardiomyopathy Registry (PCMR) from 1990-1995. Circulation 2001;104:Suppl II:II-588. abstract.
15. Manolio TA, Baughman KL, Rodeheffer R, et al. Prevalence and etiology of idiopathic dilated cardiomyopathy (summary of a National Heart, Lung, and Blood Institute workshop). Am J Cardiol 1992;69:1458-66.
16. Lipshultz SE, Lipsitz SR, Mone SM, et al. Female sex and higher drug dose as risk factors for late cardiotoxic effects of doxorubicin therapy for childhood cancer. N Engl J Med 1995; 332:1738-43.
17. Tsirka AE, Trinkaus K, Chen S-C, Lipshultz SE, Exil V, Strauss A. The "unnatural" history of pediatric dilated cardiomyopathy. Circulation 2000;102:Suppl II:II-406. abstract.
18. Chang RK, Chen AY, Klitzner TS. Female sex as a risk factor for in-hospital mortality among children undergoing cardiac surgery. Circulation 2002;106:1514-22.
19. Stein H, Shnier MH, Wayburne S, Isaacson C. Cardiomyopathy in African children. Arch Dis Child 1964;39:610-7.
20. Greenwood RD, Nadas AS, Fyler DC. The clinical course of primary myocardial disease in infants and children. Am Heart J 1976;92:549-60.
21. Pongpanich B, Isaraprasart S. Congestive cardiomyopathy in infants and children: clinical features and natural history. Jpn Heart J 1985;27:11-5.
22. Taliercio CP, Seward JB, Driscoll DJ, Fisher LD, Gersh BJ, Tajik AJ. Idiopathic dilated cardiomyopathy in the young: clinical profile and natural history. J Am Coll Cardiol 1985;6:1126-31.
23. Griffin ML, Hernandez A, Martin TC, et al. Dilated cardiomyopathy in infants and children. J Am Coll Cardiol 1988;11:139-44.
24. Chen SC, Nouri S, Balfour I, Jureidini S, Appleton RS. Clinical profile of congestive cardiomyopathy in children. J Am Coll Cardiol 1990;15:189-93.
25. Carvalho JS. Cardiomyopathies. In: Anderson RH, Baker EJ, Macartney FJ, Rigby ML, Shinebourne EA, Tynan M, eds. Paediatric cardiology. 2nd ed. London: Churchill Livingstone, 2002:1595-643.
26. Coughlin SS,Comstock GW, Baughman KL. Descriptive epidemiology of idiopathic dilated cardiomyopathy in Washington County, Maryland, 1975-1991. J Clin Epidemiol 1993;46:1003-8.
27. Correa-Villasenor A, McCarter R, Downing J, Ferencz C. White-black differences in cardiovascular malformations in infancy and socioeconomic factors. Am J Epidemiol 1991;134:393-402.
28. Boneva RS, Botto LD, Moore CA, Yang Q, Correa A, Erickson JD. Mortality associated with congenital heart defects in the United States: trends and racial disparities, 1979-1997. Circulation 2001;103:2376-81.
29. Ferencz C, Neill CA. Cardiomyopathy in infancy: observations in an epidemiologic study. Pediatr Cardiol 1992;13:65-71.
30. 2 HIV): a cohort study. Lancet 2002;360:368-73.
31. Simbre VC, Sinkin RA, Hart S, et al. Unsuspected myocardial injury in otherwise healthy newborns. Pediatr Res 2002;51: Suppl:37A. abstract.
32. Schmaltz A, Apitz J, Hort W. Dilated cardiomyopathy in childhood: problems of diagnosis and long-term follow-up. Eur Heart J 1987;8:100-5.
33. Maron BJ, Bonow RO, Cannon RO III, Leon MB, Epstein SE. Hypertrophic cardiomyopathy: interrelations of clinical manifestations, pathophysiology and therapy. N Engl J Med 1987;316:780-9, 844-52.
34. Maron BJ. Hypertrophic cardiomyopathy. In: Allen HD, Clark EB, Gutgesell HP, Driscoll DJ, eds. Moss and Adams' heart disease in infants, children, and adolescents: including the fetus and young adult. 6th ed. Vol. 2. Philadelphia: Lippincott Williams & Wilkins, 2001:1167-86.
35. Maron BJ, Roberts WC. Cardiomyopathies in the first two decades of life. In: Engle MA, ed. Pediatric cardiovascular disease. Vol. 11 of Cardiovascular clinics. Philadelphia: F.A. Davis, 1981:35-78.
36. Cannan CR, Reeder GS, Bailey KR, Melton LJ III, Gersh BJ. Natural history of hypertrophic cardiomyopathy: a population-based study, 1976 through 1990. Circulation 1995; 92:2488-95.
37. Towbin JA, Lipshultz SE. Genetics of neonatal cardiomyopathy. Curr Opin Cardiol 1999;14:250-62.
38. Towbin JA. Cardiomyopathies. In: Moller JH, Hoffman JIE, eds. Pediatric cardiovascular medicine. New York: Churchill Livingstone, 2000:753-67.